Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Boomers are leaving the stock market. Here's what comes next, says this strategist.
12:35pm, Thursday, 28'th Apr 2022 MarketWatch
Our call of the day from TS Lombard chief economist Steven Blitz warns that the "golden era of Fed-controlled equity markets" is nearing an end.
Merck (MRK) Surpasses Q1 Earnings and Revenue Estimates
11:45am, Thursday, 28'th Apr 2022 Zacks Investment Research
Merck (MRK) delivered earnings and revenue surprises of 18.23% and 5.99%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
48 Inflation Busters Feature 8 Ideal Dividend Dogs
05:16am, Thursday, 28'th Apr 2022 Seeking Alpha
March-April 2022, UBS, Kiplinger, and Barron's analysts/reporters combined to list 5 sets of stocks sorted as inflation busters for 2022, featuring 8 dividend dogs.
Drug/Biotech Stocks Q1 Earnings Due on Apr 28: MRK, LLY & More
06:03pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Let us look at the five biotech/pharma companies, slated to release quarterly results on Apr 28.
Why Earnings Season Could Be Great for Merck (MRK)
12:40pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Merck (MRK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The Zacks Analyst Blog Highlights Novo Nordisk, Advanced Micro Devices, Netflix, Merck, and Marsh & McLennan
10:39am, Wednesday, 27'th Apr 2022 Zacks Investment Research
Novo Nordisk, Advanced Micro Devices, Netflix, Merck, and Marsh & McLennan have been included in this Analyst Blog.
Top Research Reports for Novo Nordisk, AMD & Netflix
09:20pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Advanced Micro Devices, Inc. (AMD), and Netflix, Inc. (NFLX).
Healthcare ETFs in Focus Ahead of Q1 Earnings
03:15pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
The healthcare sector has gained some momentum lately on investors' rush to safety in a volatile stock market. The sector is non-cyclical in nature, which in turn, is providing a cushion to the portfo
Will Merck (MRK) Beat Expectations This Earnings Season?
01:31pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda, and the new COVID-19 antiviral pill, molnupiravir when the company reports Q1 earnings.
Where Will Vertex Pharmaceuticals Be in 5 Years?
03:00pm, Monday, 25'th Apr 2022 The Motley Fool
It'll almost certainly be competing in a few new markets.
These 3 Dow Stocks Are Set to Soar in 2022's Second Half and Beyond
02:45pm, Monday, 25'th Apr 2022 The Motley Fool
Look past all the noisy, near-term headlines and remain focused on each company's bigger, long-term picture.
Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards?
12:20pm, Monday, 25'th Apr 2022 Zacks Investment Research
Higher demand for its key drugs is likely to have offset generic competition for several other drugs and may have boosted Lilly's (LLY) first-quarter sales.
5 Blue-Chip Stocks Likely to Gain on Earnings Results This Week
10:18am, Monday, 25'th Apr 2022 Zacks Investment Research
Five Dow stocks with positive Earnings ESP will report earnings results this week. These are: V, Ko, MRK, CVX and AMGN.
Merck Is Still A Strong Buy And Possibly Set To Fly To Record Highs
06:12am, Sunday, 24'th Apr 2022 Seeking Alpha
Rising interest rates have caused a tech correction and a rotation into value and quality. MRK is one of 2022's hottest blue-chips, up 14%, the mirror image of the Nasdaq.
